In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy
Authors:
- 20 September 2021
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 608, 121095
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 AG051574, RF1 AG068034)
This publication has 70 references indexed in Scilit:
- Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studiesFluids and Barriers of the CNS, 2013
- The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticlesInternational Journal of Nanomedicine, 2012
- Enhancing the therapeutic efficacy of adenovirus in combination with biomaterialsBiomaterials, 2012
- Viral and nonviral delivery systems for gene deliveryAdvanced Biomedical Research, 2012
- Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell modelsJournal of Neuroscience Methods, 2011
- Distribution of VGF peptides in the human cortex and their selective changes in Parkinson’s and Alzheimer’s diseasesJournal of Anatomy, 2010
- Nanoparticles evading the reticuloendothelial system: Role of the supported bilayerBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- The Neurotrophin-Inducible GeneVgfRegulates Hippocampal Function and Behavior through a Brain-Derived Neurotrophic Factor-Dependent MechanismJournal of Neuroscience, 2008
- Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cellsBrain Research, 2007
- Liposome targeting to mouse brain: Mannose as a recognition markerBiochemical and Biophysical Research Communications, 1988